CUR Chart
- 52-Week Range: $0.19 - $2.12
- Market Capitalization: $4.01M
- Short Percentage: 0%
- Target Price: $26.00
- Shares Outstanding: 0
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
No upcoming catalysts found
News and Press Releases
- Doximity, Inc. (DOCS) CEO Jeff Tangney on Q4 2022 Results - Earnings Call TranscriptSeeking Alpha | May 17th
- Longeveron Inc. (LGVN) CEO Geoff Green on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 17th
- Kronos Bio Announces Participation in H.C. Wainwright Global Investment ConferenceGlobeNewsWire | May 17th
- TScan Therapeutics to Participate in the H.C. Wainwright Global Investment ConferenceGlobeNewsWire | May 17th
We searched over 50 sources and couldn't find any news or press releases related to Seneca Biopharma.
Here are some articles we think you might like.
Company Info
Website: www.neuralstem.com
Address: 20271 Goldenrod Lane, Suite 2024 20876,Germantown,USA
Sector: Other
Industry: Other
Full time employees: 5
Address: 20271 Goldenrod Lane, Suite 2024 20876,Germantown,USA
Sector: Other
Industry: Other
Full time employees: 5
$CUR the bulls in here
$CUR make it rain
let’s see some green
$CUR call the SEC
$CUR keep inchin
$CUR who else excited??
$CUR bought more
$CUR is anyone really buying this shit
$CUR enjoy your weekend
$CUR looking ready to breakout soon.
$CUR go invest in a savings account if you want safe money ??